Clinical Trials on Protein Supplementation in Italy

Total 466 results

Federico II University

Recruiting

Non-Immunoglobulin E-mediated Food Allergies in Children (NIGEFA)

Non IgE Mediated Food Allergy | Food Protein-Induced Enteropathy | Food Protein-Induced Proctocolitis | Food Protein-Induced Enterocolitis Syndrome | Food Protein-induced Motility Disorders

Italy
Università degli Studi di Brescia

Completed

Very Low Protein Diet or Dialysis in Uremic Elderly?

Dialysis | Uremia | Survival | Elderly (Aged >70) | Low Protein Diet

Italy
Azienda Ospedaliera Universitaria Integrata Verona
Azienda Ospedaliera di Padova; University of Milan; Università degli Studi di...

Completed

Multicomponent Analysis of phYsical Frailty BiomarkErs: Focus on Mitochondrial Health - MAYBE (MAYBE)

Frailty | Sarcopenic Obesity | Malnutrition; Protein

Italy
Fondazione EMN Italy Onlus

Completed

RMPT for Relapsed/Refractory Multiple Myeloma (RMPT)

Multiple Myeloma

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia A

Hemophilia A

Italy
Catholic University of the Sacred Heart

Unknown

PHYSICAL ACTIVITY AND FVIII CLEARANCE: RELEVANCE FOR PERSONALIZED THERAPY IN SEVERE HAEMOPHILIA A (PHYSEMO) (PHYSEMO)

Hemophilia A

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Emotions in the Communication and Relationship Styles of Parents With Hemophilic Children.

Hemophilia A

Italy
LMU Klinikum
Seventh Framework Programme; NBIA Alliance

Recruiting

TIRCON International NBIA Registry (TIRCON)

Neurodegeneration With Brain Iron Accumulation (NBIA) | Pantothenate Kinase-associated Neurodegeneration (PKAN) | Aceruloplasminemia | Beta-Propeller Protein-Associated Neurodegeneration (BPAN) | Mitochondrial Membrane Protein Associated Neurodegeneration (MPAN) | Fatty Acid Hydroxylase-associated... and other conditions

Canada, Czechia, Germany, Italy, Netherlands, Poland, Serbia, Spain
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CCD)

Multiple Myeloma

Italy
Mario Boccadoro

Completed

Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients (MMpredict)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients

Multiple Myeloma

Italy
Italfarmaco

Terminated

Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Italy
Genenta Science
IRCCS San Raffaele

Terminated

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Multiple Myeloma

Italy
Gruppo Italiano Studio Linfomi

Completed

A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Multiple Myeloma

Italy
Mario Negri Institute for Pharmacological Research
Federico II University; IRCCS Multimedica

Completed

Proton Pump Inhibitors (PPI): a Study to Improve Appropriate Prescriptions in the Elderly (LAPTOP-PPI)

Proton Pump Inhibitor | Primary Care

Italy
Mario Boccadoro

Completed

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Multiple Myeloma

Italy
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Multiple Myeloma

Italy
European Myeloma Network
University of Turin, Italy

Completed

Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD) (CPD)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant

Multiple Myeloma

Italy
Azienda Ospedaliera San Giovanni Battista

Unknown

Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Multiple Myeloma

Italy
Stichting European Myeloma Network
Fondazione EMN Italy Onlus

Active, not recruiting

Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) (wCCyd)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Multiple Myeloma

Italy
Azienda Ospedaliera San Giovanni Battista

Completed

Serum Free Light Change in Multiple Myeloma

Multiple Myeloma

Italy
Azienda Ospedaliera San Giovanni Battista

Unknown

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Multiple Myeloma

Italy
Università Politecnica delle Marche

Completed

Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)

Multiple Myeloma

Italy
University of Turin, Italy

Enrolling by invitation

Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area.

Covid19 | Procalcitonin | C-reactive Protein | D-dimer

Italy
Federico II University

Completed

Optical Coherence Tomography (OCT) and OCT Angiography(OCTA) Deep Learning in Waldenström's Macroglobulinemia Patients (OCTA)

Waldenstrom Macroglobulinemia

Italy
Azienda Ospedaliera San Giovanni Battista

Completed

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma (MM2011)

Multiple Myeloma | Allogeneic Transplantation

Italy
Federico II University

Completed

Intensive Replacement Treatment in Haemophilia Patients With Synovitis

Hemophilia A

Italy
Gruppo Italiano Studio Linfomi

Unknown

Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

Multiple Myeloma

Italy
Azienda Ospedaliera San Giovanni Battista

Unknown

Hematopoietic Stem Cell Transplantation in Myeloma

Multiple Myeloma

Italy
Azienda Ospedaliera Universitaria Senese
Janssen-Cilag S.p.A.

Recruiting

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive (DART4MM)

Myeloma Multiple

Italy
Fondazione EMN Italy Onlus

Completed

Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD) (MRD)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients (MPRvsMEL200)

Multiple Myeloma | Newly Diagnosed Patients

Italy
Regina Elena Cancer Institute
University of Rome Tor Vergata; Campus Bio-Medico University; Sant'Eugenio Hospital...

Recruiting

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma (TEDROMM)

Multiple Myeloma

Italy
University of Turin, Italy

Recruiting

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Multiple Myeloma

Italy
Mario Boccadoro

Active, not recruiting

Immune Profiling in Multiple Myeloma

Multiple Myeloma

Italy
IRCCS San Raffaele

Completed

Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma

Multiple Myeloma

Italy
Rottapharm Biotech
Agenus Inc.

Active, not recruiting

A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients

Solid Tumor | Metastatic Microsatellite-stable Colorectal Cancer | Mismatch Repair Protein Proficient | Refractory Metastatic Colorectal Cancer

Italy
University of L'Aquila
TRIB s.r.l.

Completed

Treatment of Inherited Factor VII Deficiency (STER)

Factor VII Deficiency

Italy
Michele Cavo
Janssen-Cilag S.p.A.

Unknown

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Multiple Myeloma

Italy
University of Bari

Completed

Phase Angle and Chronic Intestinal Inflammatory Diseases (PHIBO)

Inflammatory Bowel Diseases | Mucosal Inflammation | C-Reactive Protein | Leukocyte L1 Antigen Complex

Italy
University of Turin, Italy

Active, not recruiting

Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Multiple Myeloma

Italy
Regina Elena Cancer Institute

Recruiting

Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment (AATF/Che-1)

Multiple Myeloma

Italy
Bayer

Completed

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." (POTTER 10)

Hemophilia A

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients. (DILEMMA)

Multiple Myeloma | Daratumumab | Autologous Stem Cell Transplantation | Leukapheresis

Italy
Fondazione EMN Italy Onlus

Terminated

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients (D-MP)

Myeloma

Italy

3

Subscribe